Movement Alert|Thermo Fisher Scientific Rises 3.05% in Regular Trading, Life Sciences Sector Rebounds as AI Collaboration Theme Persists

Market Focus06-04 23:30

On June 4, Thermo Fisher Scientific rose 3.05% in regular trading, trading at $488.15/share, with trading volume of $262 million. The stock recovered losses from the prior session as the life sciences tools and services sector staged a broad rebound.

On the news front, the AI-empowered life sciences theme continued to gain traction following OpenAI's recent launch of GPT-Rosalind, a model focused on life sciences research, developed in collaboration with Thermo Fisher to be integrated across various workflows. The sector saw strong collective gains, with Tempus AI surging 12.13%, Danaher rising 5.16%, IQVIA up 3.28%, and Illumina gaining 3.31%, demonstrating significant sector linkage effects.

Notably, the rebound came despite HSBC downgrading Thermo Fisher from buy to hold and cutting its price target from $670 to $540. Analyst consensus still maintains an average buy rating with a mean price target of $602.50. The company reported Q1 revenue of $11.01 billion with adjusted EPS of $5.44, both exceeding expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment